A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications
Open Access
- 31 March 2019
- journal article
- review article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 108, 44-53
- https://doi.org/10.1016/j.jclinepi.2018.12.003
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Multiple Medication Adherence and its Effect on Clinical Outcomes Among Patients With Comorbid Type 2 Diabetes and HypertensionMedical Care, 2013
- Clinical and economic outcomes associated with amlodipine/renin–angiotensin system blocker combinationsTherapeutic Advances in Cardiovascular Disease, 2013
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- Adherence to Oral Antidiabetic Agents with Pioglitazone and Metformin: Comparison of Fixed-Dose Combination Therapy with Monotherapy and Loose-Dose Combination TherapyClinical Therapeutics, 2011
- Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrolleesBMC Cardiovascular Disorders, 2010
- Comparison of Drug Adherence Rates Among Patients with Seven Different Medical ConditionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewInternational Journal of Clinical Practice, 2007
- Studying Prescription Drug Use and Outcomes With Medicaid Claims DataMedical Care, 2007
- Hypertension Management in the Elderly Has ImprovedHypertension, 2005
- Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysisClinical Therapeutics, 2004